Latest Articles

Publication Date
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy - Endocrine Society

Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy Endocrine Society

Published: Nov. 18, 2025, 9:22 a.m.
What is the 21-day Hormone Reset Diet? The science behind it explained - HELLO! Magazine

What is the 21-day Hormone Reset Diet? The science behind it explained HELLO! Magazine

Published: Nov. 18, 2025, 8:03 a.m.
Pete Davidsons girlfriend Elsie Hewitt shares alarming pregnancy pain update - Geo News

Pete Davidsons girlfriend Elsie Hewitt shares alarming pregnancy pain update Geo News

Published: Nov. 17, 2025, 3 a.m.
Traitors star is 'grateful for abnormal anatomy' - AOL.com

Traitors star is 'grateful for abnormal anatomy' AOL.com

Published: Nov. 16, 2025, 5:44 p.m.
'I thought my chronic pain would stop me working but I never gave up' - Birmingham Live

'I thought my chronic pain would stop me working but I never gave up' Birmingham Live

Published: Nov. 16, 2025, 5:24 a.m.
Penarth seafront restaurant floods as Storm Claudia hits - BBC

Penarth seafront restaurant floods as Storm Claudia hits BBC

Published: Nov. 15, 2025, 8:46 a.m.
Seafront flooded as Storm Claudia hits Wales - BBC

Seafront flooded as Storm Claudia hits Wales BBC

Published: Nov. 15, 2025, 8:33 a.m.
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post

FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post

Published: Nov. 14, 2025, 3:26 p.m.
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - BioSpace

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) BioSpace

Published: Nov. 14, 2025, 11:59 a.m.
Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) - Morningstar

Ingenus Pharmaceuticals Announces FDA Approval and Launch of First and Only Generic Equivalent to Premarin® Tablets (Conjugated Estrogens Tablets, USP) Morningstar

Published: Nov. 13, 2025, 3:15 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!